Fionnuala Crowley, Integrated Oncologist and Palliative Care Fellow at Mount Sinai Hematology shared a post on X:
“Thanks to everyone who was so supportive of our EGFR Choices Study during ASCO 2026.
We only need a few more responses to reach our oncologist target!!! If you’re an oncologist who sees patients with lung cancer would love to hear from you at QR code below!
Also if you would like to collaborate on this study and collect surveys from patients at your site please get in touch. No IRB or DUA required!”
Other articles about ASCO on OncoDaily.